Trial ID or NCT#
We hope to determine the maximum tolerated dose of 3 session (i.e., treatment) stereotactic radiosurgery to treat brain metastases greater than 4.2 cm3 in size. By increasing radiation dose, we will determine if there is a better outcome without greater toxicity (side effects) for patients.
A Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
Contact us to find out if this trial is right for you.